Rialto Wealth Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Rialto Wealth Management's PBYI Position: Q3 2026 in Review
Rialto Wealth Management sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 1,450 shares — an estimated $11.8K sold.
Rialto Wealth Management first reported a position in PBYI in Q1 2025 and held it in 6 quarters. The position peaked at $11.8K in Q2 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Rialto Wealth Management reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
- Rialto Wealth Management sold 1,450 Puma Biotechnology shares in Q3 2026, an estimated $11.8K.
- Rialto Wealth Management first reported a position in Puma Biotechnology in Q1 2025 and held it in 6 quarters.
- Rialto Wealth Management's Puma Biotechnology position peaked at $11.8K in Q2 2026.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.